Prospective interventional trial in lowlanders evaluating the effect of acute exposure, acclimatization and re-exposure to high altitude on cerebral autoregulation
Baseline measurements will be performed in Santiago de Chile, 520 m, over the course of 3 days. Participants will then travel by commercial airline (5 h flight) and by bus (3 h ride) to the ALMA base camp located at 2900 m near San Pedro de Atacama, northern Chile. Participants will stay there for the next 8 nights and they will be spend the days (6-8 h daily) at the telescope station at 5050 m while undergoing testing as described above at the first and the last day at 5050m. Daily transports from 2900 to 5050 m will be by car (1 h ride, one way). After the first 8 day altitude sojourn participants will return to the Santiago area (520 m) for a 6 day recovery period. A second altitude sojourn with an identical schedule as the one described above and a final low altitude stay of 3 days will follow.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
21
altitude exposure
University of Zurich
Zurich, Switzerland
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
Change in magnitude of the coefficient of coherence between blood flow velocity in the middle cerebral artery measured by transcranial ultrasound Doppler and systemic blood pressure at day 2 (5050 m) vs. day 1 (520 m) of the first cycle
Time frame: day 1; day 2 first cycle
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
Change in magnitude of the coefficient of coherence between blood flow velocity in the middle cerebral artery measured by transcranial ultrasound Doppler and systemic blood pressure at day 7 (5050 m) vs. day 1 (520 m) of the first cycle.
Time frame: day 1; day 7 first cycle
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
Change in magnitude of the coefficient of coherence between blood flow velocity in the middle cerebral artery measured by transcranial ultrasound Doppler and systemic blood pressure at day 7 (5050 m) vs. day 2 (5050 m) of the second cycle.
Time frame: day 2; day 7 second cycle
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
Change in magnitude of the coefficient of coherence between blood flow velocity in the middle cerebral artery measured by transcranial ultrasound Doppler and systemic blood pressure at day 2 (5050 m) second cycle vs. day 2 (5050 m) of the first cycle.
Time frame: day 2 first cycle; day 2 second cycle
Coherence between middle cerebral artery blood flow velocity and systemic blood pressure as measure of cerebral autoregulation.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in magnitude of the coefficient of coherence between blood flow velocity in the middle cerebral artery measured by transcranial ultrasound Doppler and systemic blood pressure at day 7 (5050 m) second cycle vs. day 7 (5050 m) of the first cycle.
Time frame: day 7 first cycle; day 7 second cycle